 |
Welcome to |
|
BEAVERTON, Ore., Sept. 2 /PRNewswire/ -- Epitope, Inc. (Nasdaq: EPTO) today announced that its wholly owned subsidiary, Agritope, Inc., has filed a registration statement with the Securities and Exchange Commission with respect to Epitope's previously announced intention to spin off its Agritope agricultural biotechnology subsidiary. The spin-off will be accomplished through a dividend distribution to Epitope shareholders of all Agritope common stock held by Epitope. As a result of the spin-off, Agritope will cease to be a wholly owned subsidiary of Epitope and will operate as an independent public company. Epitope shareholders will not have to pay for any shares of Agritope stock received in the distribution or take any action to receive shares. Completion of the spin-off is contingent upon obtaining financing for Agritope sufficient to operate it as an independent public company and satisfaction of certain other conditions, including a review of the registration statement by the SEC. Agritope is a biotechnology company specializing in the development of new fruit and vegetable plant varieties. Agritope is also the majority owner of Vinifera, Inc., which offers grapevine plant propagation and disease screening and elimination programs. Epitope, Inc. is a biotechnology company that develops and markets medical diagnostic products. NOTE: A registration statement relating to these securities has been filed with the Securities and Exchange Commission. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state. Source: EPITOPE Inc. Content of this page is copyright and reprinted here for educational and historical information. |
||
